Insomnia is the most prevalent sleep disorder in the US. In-home insomnia monitoring is important for both diagnosis and treatment. Existing solutions, however, require the user to either maintain a sleep diary or wear a sensor while sleeping. Both can be quite cumbersome. This paper introduces EZ-Sleep, a new approach for monitoring insomnia and sleep.

Kabelac & Hristov are among the cofounders of Emerald Innovations, the producer of a wireless home sensor that can measure movement, respiration, heart rate, sleep and behavior of patients by using low power radio waves. This allows the Emerald device to capture valuable patient home data through walls without touching or disturbing the patient in any way.

MIT has developed an ‘invisible’ device that provides several benefits over traditional patient data collection methods, including improved biomarker development and the ability to detect changes in behavior – by monitoring patients wirelessly, and through walls.

The COVID-19 pandemic has presented an unprecedented challenge for healthcare workers. Among the major challenges are social distancing issues, which have required novel approaches to diagnosing and treating illness.

For many who have already tested positive, home stays are the best option to avoid an already massively overtaxed hospital system in many areas and to avoid further infecting others. The question, then, is how doctors and nurses can continue to provide treatment remotely with the pronounced limitations of telemedicine.

Gait velocity and stride length are critical health indicators for older adults. A decade of medical research shows that they provide a predictor of future falls, hospitalization, and functional decline among seniors. However, currently these metrics are measured only occasionally during medical visits. Such infrequent measurements hamper the opportunity to detect changes and intervene early in the impairment process.

We focus on predicting sleep stages from radio measurements without any attached sensors on subjects. We introduce a new predictive model that combines convolutional and recurrent neural networks to extract sleep-specific subjectinvariant features from RF signals and capture the temporal progression of sleep. A key innovation underlying our approach is a modified adversarial training regime that discards extraneous information specific to individuals or measurement conditions, while retaining all information relevant to the predictive task. We analyze our game theoretic setup and empirically demonstrate that our model achieves significant improvements over state-of-the-art solutions.

RF-Pose provides accurate human pose estimation through walls and occlusions. It leverages the fact that wireless signals in the WiFi frequencies traverse walls and reflect off the human body. It uses a deep neural network approach that parses such radio signals to estimate 2D poses. RF-Pose is trained using state-of-the-art vision model to provide cross-modal supervision. Once trained, RF-Pose uses only the wireless signal for pose estimation. Experimental results show that, when tested on visible scenes, the radio-based system is almost as accurate as the vision-based system used to train it. Yet, unlike vision-based pose estimation, the radio-based system can estimate 2D poses through walls despite never trained on such scenarios.

Understanding users’ behavior at home is central to behavioral research. For example, social researchers are interested in studying domestic abuse, and healthcare professionals are interested in caregiver-patient interaction. Today, such studies rely on diaries and questionnaires, which are subjective, erroneous, and hard to sustain in longitudinal studies

FSHD is a rare, slowly progressive myopathy characterized by weakness initially in facial, shoulder, and upper limb muscles followed by abdominal and paraspinal weakness, and finally lower extremity weakness. FSHD affects between 16,000–38,000 people in the US, and its symptoms often progress over decades, creating significant challenges in tracking disease progression using in-clinic scales and functional tests.

Emerald Innovations - 1 Broadway 14FL, Cambridge MA, 02142
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram